534 related articles for article (PubMed ID: 17722952)
1. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
Bell DS
Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
[TBL] [Abstract][Full Text] [Related]
2. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
3. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
4. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.
Chatterjee S; Tringham JR; Davies MJ
Expert Opin Pharmacother; 2006 Jul; 7(10):1357-71. PubMed ID: 16805721
[TBL] [Abstract][Full Text] [Related]
5. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
Dunn CJ; Plosker GL
Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
[TBL] [Abstract][Full Text] [Related]
6. Premixed insulin analogues for the treatment of diabetes mellitus.
Garber AJ
Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
[TBL] [Abstract][Full Text] [Related]
7. Innovative insulins--where do analogues fit?
Phillips LK; Phillips PJ
Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
[TBL] [Abstract][Full Text] [Related]
8. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
9. [The new insulins].
Krzentowski G
Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of insulin analogues for diabetes mellitus.
Cameron CG; Bennett HA
CMAJ; 2009 Feb; 180(4):400-7. PubMed ID: 19221353
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
[TBL] [Abstract][Full Text] [Related]
12. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
Crasto W; Jarvis J; Khunti K; Davies MJ
Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
[TBL] [Abstract][Full Text] [Related]
13. Insulin analogues: new dimension of management of diabetes mellitus.
Siddiqui NI
Mymensingh Med J; 2007 Jan; 16(1):117-21. PubMed ID: 17344794
[TBL] [Abstract][Full Text] [Related]
14. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
Ulrich H; Snyder B; Garg SK
Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
[TBL] [Abstract][Full Text] [Related]
15. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
16. New insulins in the treatment of diabetes mellitus.
Lindholm A
Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
[TBL] [Abstract][Full Text] [Related]
17. Narrative review: a rational approach to starting insulin therapy.
Mooradian AD; Bernbaum M; Albert SG
Ann Intern Med; 2006 Jul; 145(2):125-34. PubMed ID: 16847295
[TBL] [Abstract][Full Text] [Related]
18. The past, present, and future of basal insulins.
Pettus J; Santos Cavaiola T; Tamborlane WV; Edelman S
Diabetes Metab Res Rev; 2016 Sep; 32(6):478-96. PubMed ID: 26509843
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P; Woodworth JR
Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
[TBL] [Abstract][Full Text] [Related]
20. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
Wilde MI; McTavish D
Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
